AJJ Medtech Holdings Limited Share Price

Equities

584

SG0584008601

Medical Equipment, Supplies & Distribution

Market Closed - Singapore S.E. 01:25:53 30/04/2024 pm IST 5-day change 1st Jan Change
0.005 SGD -.--% Intraday chart for AJJ Medtech Holdings Limited +25.00% -28.57%

Financials

Sales 2022 779K 571K 47.63M Sales 2023 1.62M 1.18M 98.74M Capitalization 6.54M 4.79M 400M
Net income 2022 -4M -2.93M -245M Net income 2023 -2M -1.47M -122M EV / Sales 2022 11.1 x
Net Debt 2022 1.14M 837K 69.88M Net Debt 2023 2.46M 1.81M 151M EV / Sales 2023 5.57 x
P/E ratio 2022
-1.76 x
P/E ratio 2023
-2.59 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 57.17%
More Fundamentals * Assessed data
Dynamic Chart
1 week+25.00%
Current month-16.67%
1 month-16.67%
3 months-16.67%
Current year-28.57%
More quotes
1 week
0.00
Extreme 0.004
0.01
1 month
0.00
Extreme 0.004
0.01
Current year
0.00
Extreme 0.004
0.01
1 year
0.00
Extreme 0.004
0.01
3 years
0.00
Extreme 0.004
0.02
5 years
0.00
Extreme 0.003
0.04
10 years
0.00
Extreme 0.003
0.08
More quotes
Managers TitleAgeSince
Chief Executive Officer 34 20/20/20
Director of Finance/CFO - 25/02/25
Corporate Officer/Principal 37 28/23/28
Members of the board TitleAgeSince
Director/Board Member 59 14/23/14
Director/Board Member 44 30/20/30
Chief Executive Officer 34 20/20/20
More insiders
Date Price Change Volume
30/24/30 0.005 -.--% 270,000
29/24/29 0.005 +25.00% 500,000
25/24/25 0.004 -20.00% 39,500
24/24/24 0.005 +25.00% 2,820,600
23/24/23 0.004 -.--% 698,800

Delayed Quote Singapore S.E., April 30, 2024 at 01:25 pm IST

More quotes
AJJ Medtech Holdings Ltd is a Singapore-based investment holding company. The Company is primarily involved in the provision of childcare wellness education services and the selling and distribution of healthcare and medical diagnostic imaging products. The Company’s business segments include Ultrasound, In-vitro Diagnostics (IVD) and Life Science, Medical Devices, and Dental Devices. Ultrasound business segment includes general imaging, women's health, and point-of-care applications. In-vitro Diagnostics and Life Sciences business includes Point-of-care diagnostics, such as ACON On Call Blood Glucose Monitoring System and Single-use rapid test kits and Laboratory diagnostics and life science includes Portable diagnostics equipment and Reagents and consumables. Medical devices business segment includes High-intensity Focused Ultrasound (HIFU), General and plastic surgery devices, such as Staplers and cutters, Ward-side consumables, and CareX Bed-side care robotics solutions.
More about the company